COVID-19
|
SUBSCRIBE
|
FAQs
HOME
ABOUT US
WHO WE ARE
THE SAHPRA BOARD
EXECUTIVE MANAGEMENT
REGULATORY PARTNERSHIP
SPECIAL PROJECTS
BACKLOG
VACANCIES
NEWS
LATEST NEWS & UPDATES
PRESS RELEASES
NDOH Updates
PRESENTATIONS
SAFETY ALERTS
UPCOMING EVENTS
WORKSHOPS AND CONFERENCES
SAHPRA TV
HEALTH PRODUCTS
ORTHODOX MEDICINES
GUIDELNES
TEMPLATES
BIOLOGICAL PRODUCTS
GUIDELINES
COMPLEMENTARY MEDICINES
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
TEMPLATES
MEDICAL DEVICES
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
MEDICAL DEVICES LICENCES ISSUED
POSITION STATEMENTS
RELATED DOCUMENTS
TEST KITS
RADIATION CONTROL
ACTS AND REGULATIONS
APPLICATION AND REPORT FORMS
GUIDELNES AND CODES OF PRACTICE
UNREGISTERED PRODUCTS
GUIDELINES
VETERINARY MEDICINES
GUIDELNES
E-SERVICES
ACCESS TO UNREGISTERED HEALTH PODUCTS
ADVERSE DRUG REACTION REPORTING
COMPLEMENTARY MEDICINES LICENSING
COVI-VIG REPORTING SYSTEM
HEALTH PRODUCT APPLICATION STATUS CHECKER
PRODUCT VARIATIONS PORTAL
THE MED SAFETY APP
PUBLICATIONS
ACTS AND REGULATIONS
ANNUAL REPORT
CORPORATE IDENTITY
GOVERNMENT GAZETTES AND REGULATIONS
GUIDELINES
FEES
PRESENTATIONS
SAHPRA PLANNING DOCUMENTS
TENDERS
CONTACT US
HEAD OFFICE
KEY CONTACTS
MEDIA ENQUIRIES
FEEDBACK AND COMPLAINTS
HOME
ABOUT US
WHO WE ARE
THE SAHPRA BOARD
EXECUTIVE MANAGEMENT
REGULATORY PARTNERSHIP
SPECIAL PROJECTS
BACKLOG
VACANCIES
NEWS
LATEST NEWS & UPDATES
PRESS RELEASES
NDOH Updates
PRESENTATIONS
SAFETY ALERTS
UPCOMING EVENTS
WORKSHOPS AND CONFERENCES
SAHPRA TV
HEALTH PRODUCTS
ORTHODOX MEDICINES
GUIDELNES
TEMPLATES
BIOLOGICAL PRODUCTS
GUIDELINES
COMPLEMENTARY MEDICINES
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
TEMPLATES
MEDICAL DEVICES
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
MEDICAL DEVICES LICENCES ISSUED
POSITION STATEMENTS
RELATED DOCUMENTS
TEST KITS
RADIATION CONTROL
ACTS AND REGULATIONS
APPLICATION AND REPORT FORMS
GUIDELNES AND CODES OF PRACTICE
UNREGISTERED PRODUCTS
GUIDELINES
VETERINARY MEDICINES
GUIDELNES
E-SERVICES
ACCESS TO UNREGISTERED HEALTH PODUCTS
ADVERSE DRUG REACTION REPORTING
COMPLEMENTARY MEDICINES LICENSING
COVI-VIG REPORTING SYSTEM
HEALTH PRODUCT APPLICATION STATUS CHECKER
PRODUCT VARIATIONS PORTAL
THE MED SAFETY APP
PUBLICATIONS
ACTS AND REGULATIONS
ANNUAL REPORT
CORPORATE IDENTITY
GOVERNMENT GAZETTES AND REGULATIONS
GUIDELINES
FEES
PRESENTATIONS
SAHPRA PLANNING DOCUMENTS
TENDERS
CONTACT US
HEAD OFFICE
KEY CONTACTS
MEDIA ENQUIRIES
FEEDBACK AND COMPLAINTS
Covid-19 Tag
News & Updates
Guidance on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine in pregnant and lactating women
April 29, 2021
News & Updates
Press Releases
SAHPRA Statement – Update on Sisonke Phase 3B Implementation Study
April 17, 2021
News & Updates
Press Releases
Statement by the Minister of Health, Dr Zwelini Mkhize, on the FDA’s Temporary Suspension of Johnson and Johnson vaccine rollout in the United States.
April 13, 2021
News & Updates
Press Releases
SAHPRA Statement- High Court Order – Ivermectin
April 9, 2021
News & Updates
SAHPRA registers Covid-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) with conditions
April 1, 2021
Press Releases
SAHPRA registers the COVID-19 Vaccine Janssen
April 1, 2021
News & Updates
Regulatory stringency and adaptability in the time of COVID-19
March 25, 2021
News & Updates
Press Releases
SAHPRA and the Pfizer/Biontech Comirnaty Vaccine
March 16, 2021
Press Releases
SAHPRA and the CoronaVac Vaccine
March 12, 2021
Press Releases
Update: SAHPRA and the SputnikV Vaccine
February 24, 2021
1
2
3
